#16
|
|||
|
|||
Ðèñê ïåðåäà÷è íîâîðîæäåííîìó îò çàðàæåííîé ìàòåðè
Ïðè ïåðâè÷íîì ýïèçîäå ãåðïåñà ðèñê ïåðåäà÷è 50% Ïðè ðåöèäèâèðóþùåé èíôåêöèè èëè àñèìïòîìíîì òå÷åíèè 0-4% ïðàâèëüíî ëè ÿ ïîíèìàþ, ÷òî ðèñê 0-4%, âêëþ÷àåò è ìîìåíò ïðîõîæäåíèÿ ÷åðåç ðîäîâûå ïóòè? ò.å ýòî îáùèè ðèñê? |
#17
|
|||
|
|||
Öèòàòà:
- ðèñê âî âðåìÿ ðîäîâ ìíîãîêðàòíî âûøå-íàèáîëüøèé, ýòîãî èìåííî è îïàñàþòñÿ-ïåðåäà÷è âî âðåìÿ ðîäîâ Öèòàòà:
|
#18
|
|||
|
|||
ñïàñèáî! ñêàæèòå ïîæàéëóñòà, íà ðàííåì ñðîêå ïëîä òàêæå çàùèùåí àíòèòåëàìè êàê è íà ïîçäíèõ? åñòü ðàçíèöà?
|
#19
|
|||
|
|||
ñïàñèáî! ñêàæèòå ïîæàéëóñòà, íà ðàííåì ñðîêå ïëîä òàêæå çàùèùåí àíòèòåëàìè êàê è íà ïîçäíèõ? åñòü ðàçíèöà?
âîò íàøëà Âàø îòâåò: ðèñê âíóòðèóòðîáíîãî èíôèöèðîâàíèÿ åñòü, ïóñòü è íå áîëüøîé, íî ýòî îïÿòü æå áîëåå ïîçäíèå ñðîêè Îáüÿñíèòå ïîæàéëóñòà ïðî èíôèöèðîâàíèå ðàííèå/ïîçäíèå ñðîêè. |
#20
|
|||
|
|||
ñêàæèòå ïîæàéëóñòà, íà ðàííåì ñðîêå ïëîä òàêæå çàùèùåí àíòèòåëàìè êàê è íà ïîçäíèõ? åñòü ðàçíèöà?
- ñìûñë âîïðîñà óòî÷íèòå, ïîæàëóéñòà; ïëîä âåäü çàùèùåí îò ïðîíèêíîâåíèÿ âèðóñà â ïðèíöèïå-îò çàðàæåíèÿ, êîòîðîå â íîðìå íå äîëæíî ïðîèñõîäèòü âî âðåìÿ áåðåìåííîñòè â ëþáîì ñëó÷àå âîò íàøëà Âàø îòâåò: ðèñê âíóòðèóòðîáíîãî èíôèöèðîâàíèÿ åñòü, ïóñòü è íå áîëüøîé, íî ýòî îïÿòü æå áîëåå ïîçäíèå ñðîêè Îáüÿñíèòå ïîæàéëóñòà ïðî èíôèöèðîâàíèå ðàííèå/ïîçäíèå ñðîêè. - â öåëîì ïî ðåçóëüòàòàì êðóïíûõ ìàñøòàáíûõ èññëåäîâàíèé ðèñê âñå òîò æå, ÷òî è îçâó÷åí ðàíåå, ðàçáðîñ áóäåò âñå â òåõ æå ïðîöåíòàõ íà ñðîêàõ, ïîýòîìó íå ïðèíöèïèàëåí; òîëüêî ñîçäàåòå äëÿ ñåáÿ ïîâîä äëÿ ïåðåæèâàíèé, ìîæåò áûòü ïîìîùü ïñèõîëîãà, ÷òîáû ïîääåðæàòü íà ýòîì ýòàïå Âàñ? ïîòîìó ÷òî òàê ìîæíî ñîçäàòü ñåáå ïðîáëåìû òàì, ãäå èõ ïîêà íåò(îáðàùåíèå â öåíòðû ñ ñîìíèòåëüíûìè ìåòîäàìè, åñëè ÊÄ-"êîìïüþòåðíàÿ äèàãíîñòèêà", äàæå åñëè â öåíòðå ÊÄ-ìåòîä ïîñåâà ÂÏÃ-åñòü è òàêîé èç ñîâðåìåííûõ, òàêîå êîëè÷åñòâî àíàëèçîâ ïðîñòî ìîæåò áûòü íå ïîêàçàíî è íå èçìåíèò â èòîãå îñíîâíîãî ïîäõîäà âåäåíèÿ áåðåìåííîñòè, âñå ñâîäèòñÿ âñå îäíîìó è òîìó æå-ïðèåì ïðîòèâîâèðóñíûõ ïðåïàðàòîâ, ïëàíèðîâàíèå ðîäîâ - ìàòü ïåðåäàåò ñâîè àíòèòåëà ïëîäó è ýòî ïîçâîëÿåò èìåòü çàùèòó íîâîðîæäåííîìó ïîñëå ðîäîâ, âîçìîæíî Âû ÷èòàëè ïðî ýòî? - â ëþáîì ñëó÷àå ïëàíèðóåòñÿ ëèáî êåñàðåâî ñå÷åíèå, ëèáî ïðèìåíåíèå àöèêëîâèðà è ðîäîðàçðåøåíèå-ò.å. ñî ñâîèì ãèíåêîëîãîì îöåíèâàþòñÿ âñå ðèñêè è ïðèíèìàåòñÿ ðåøåíèå, ò.å. â ëþáîì ñëó÷àå ñïåöèàëèñòû íå ïðåäëîæàò êàêèå-ëèáî "îñîáûå" ìåòîäû ëå÷åíèÿ â íîðìå - îáðàòèòüñÿ â öåíòð, åñëè êîíå÷íî ÊÄ-ïðîñòî îäèí èç ñîâðåìåííûõ ìåòîäîâ äèàãíîñòèêè, èìåííî êàê àíàëèç, íå êîìïüþòåðíàÿ äèàãíîñòèêà, ìîæåò è ìîæíî, íî âàæíî ïîíèìàòü, ÷òî ìåðû âñå òåæå, òàêòèêà â ëå÷åíèè ñîõðàíÿåòñÿ âñå òà æå |
#21
|
|||
|
|||
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
- âñå îñíîâíûå äàííûå åñòü ïî ýòîé ññûëêå - ïî÷åìó îòëè÷àþòñÿ öèôðû: áîëüøèíñòâî ñëó÷àåâ ïåðåäà÷è ÂÏà èìåííî âî âðåìÿ ðîäîâ; â ñðåäíåì 5% íîâîðîæäåííûõ ñ ãåðïåñîì(ñêîðåå ðå÷ü øëà îá ýòèõ öèôðàõ) ïðèîáðåòàþò âî âðåìÿ áåðåìåííîñòè(0-4%, 0-5%-ýòî ðèñê çàðàæåíèÿ èìåííî ó ïàöèåíòîâ ñ ðåöèäèâèðóþùèì ÃÃ-ýòè öèôðû òàê è îñòàþòñÿ, ÷àñòî ïóòàþò ñ ïðîöåíòîì íîâîðîæäåííûõ) - çà âðåìÿ áåðåìåííîñòè àíòèòåëà ìàòåðè ÷åðåç ïëàöåíòó ïîïàäàþò ê ðåáåíêó, êîòîðûå çàùèùàþò ðåáåíêà íîâîðîæäåííîãî - ìåòîäû äèàãíîñòèêè(êóëüòóðà, ÊÄ-êóëüòóðàëüíàÿ äèàãíîñòèêà, âîçìîæíî ïðîâîäèëè òàêîå èññëåäîâàíèå Âàì, ÏÖÐ, ìåòîä Òöàíêà), ÏÖÐ-ïðåäïîëàãàþò, ÷òî â èòîãå áóäåò ñòàíäàðòîì äèàãíîñòèêè - ðåêîìåíäàöèè âñå òåæå: "Level B recommendations (based on limited or inconsistent scientific evidence) Women with active recurrent genital herpes should be offered suppressive viral therapy at or beyond 36 weeks of gestation. - æåíùèíû ñ ðåöèäèâàìè -ïðîòèâîâèðóñíàÿ ïåðåä ðîäàìè Cesarean delivery is indicated in women with active genital lesions or prodromal symptoms (eg, vulvar pain or burning) at the time of delivery, because these symptoms may indicate an impending outbreak. Level C recommendations (based on consensus or expert opinion) In women with premature rupture of membranes, there is no consensus on the gestational age at which the risks of prematurity outweigh the risks of HSV infection. Cesarean delivery is not recommended for women with a history of HSV infection but no active genital disease during labor. Routine antepartum genital HSV cultures in asymptomatic patients with recurrent disease are not recommended. - ðóòèííîå èññëåäîâàíèå âî âðåìÿ áåðåìåííîñòè êóëüòóðàëüíîå(ÊÄ) íå ðåêîìåíäóåòñÿ Routine HSV screening of pregnant women is not recommended." - ñêðèíèíã òàêæå íå ðåêîìåíäóåòñÿ |
#22
|
|||
|
|||
11.11.11 ðîäèëà ìàëü÷èêà, 3600, 52 ñì. Ìàðèÿ Þðüåâíà íèçêèé Âàì ïîêëîí çà ïîääåðæêó âî âðåìÿ áåðåìåííîñòè!
|
|
#23
|
|||
|
|||
Èñêðííå Âàñ ïîçäðàâëÿåì! Çäîðîâüÿ! Æåëàåì Âàì "çäîðîâîãî ìàëûøà ÐÌÑ"
|